• Processa Pharmaceuticals CFO Russell Skibsted bought 1,984 shares of common stock at USD 2.97 per share.
• Skibsted’s direct holding rose to 8,466 shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Processa Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000897069-26-001171), on May 19, 2026, and is solely responsible for the information contained therein.